Witz IP - Search Results

1

Progression of mouse mammary tumors: MCP-1-TNFalpha cross-regulatory pathway and clonal expression of promalignancy and antimalignancy factors.

Neumark E, Sagi-Assif O, Shalmon B, Ben-Baruch A, Witz IP. Neumark E, et al. Among authors: witz ip. Int J Cancer. 2003 Oct 10;106(6):879-86. doi: 10.1002/ijc.11337. Int J Cancer. 2003. PMID: 12918065

2

FcR may function as a progression factor of nonlymphoid tumors.

Witz IP, Ran M. Witz IP, et al. Immunol Res. 1992;11(3-4):283-95. doi: 10.1007/BF02919134. Immunol Res. 1992. PMID: 1287122 Review.

3

In vivo tumorigenicity and in vitro sensitivity to tumor-necrosis-factor alpha mediated killing of c-Ha-ras-transformed cells.

Gonen B, Kahana O, Witz IP. Gonen B, et al. Among authors: witz ip. Cancer Immunol Immunother. 1992;35(6):388-94. doi: 10.1007/BF01789017. Cancer Immunol Immunother. 1992. PMID: 1327528 Free PMC article.

4

In vivo acquisition of Fc gamma RII expression on polyoma virus-transformed cells derived from tumors of long latency.

Ran M, Katz B, Kimchi N, Halachmi E, Teillaud JL, Even J, Berko-Flint Y, Atlas E, Fridman WH, Witz IP. Ran M, et al. Among authors: witz ip. Cancer Res. 1991 Jan 15;51(2):612-8. Cancer Res. 1991. PMID: 1845956

5

Some cellular and molecular characteristics of high and low tumorigenicity variants of polyoma-virus transformed cells.

Berko-Flint Y, Fridman WH, Grossman-Atlas E, Kimchi N, Ben-Baruch AL, Moss S, Teillaud JL, Witz IP, Ran M. Berko-Flint Y, et al. Among authors: witz ip. Mol Immunol. 1990 Dec;27(12):1219-28. doi: 10.1016/0161-5890(90)90025-u. Mol Immunol. 1990. PMID: 2177146

6

Differential tumorigenicity of 3T3 cells transformed in vitro with polyoma virus and in vivo selection for high tumorigenicity.

Halachmi E, Witz IP. Halachmi E, et al. Among authors: witz ip. Cancer Res. 1989 May 1;49(9):2383-9. Cancer Res. 1989. PMID: 2539901

7

Microenvironmental factors regulate Ly-6 A/E expression on PyV-transformed BALB/c 3T3 cells.

Eshel R, Firon M, Katz BZ, Sagi-Assif O, Aviram H, Witz IP. Eshel R, et al. Among authors: witz ip. Immunol Lett. 1995 Jan;44(2-3):209-12. doi: 10.1016/0165-2478(94)00216-e. Immunol Lett. 1995. PMID: 7797253

8

An association between high Ly-6A/E expression on tumor cells and a highly malignant phenotype.

Katz BZ, Eshel R, Sagi-Assif O, Witz IP. Katz BZ, et al. Among authors: witz ip. Int J Cancer. 1994 Dec 1;59(5):684-91. doi: 10.1002/ijc.2910590517. Int J Cancer. 1994. PMID: 7960242

9

Myeloproliferation in long-term plasmacytoma-regressor mice.

Sagi-Assif O, Douer D, Shaked N, Russell SW, Witz IP. Sagi-Assif O, et al. Among authors: witz ip. Int J Cancer. 1994 Jan 15;56(2):208-13. doi: 10.1002/ijc.2910560211. Int J Cancer. 1994. PMID: 8314303

10

The murine Fc-gamma (Fc gamma) receptor type II B1 is a tumorigenicity-enhancing factor in polyoma-virus-transformed 3T3 cells.

Zusman T, Gohar O, Eliassi H, Avivi Y, Lisansky E, Sautes C, Even J, Bonnerot C, Fridman WH, Witz IP, Ran M. Zusman T, et al. Among authors: witz ip. Int J Cancer. 1996 Jan 17;65(2):221-9. doi: 10.1002/(SICI)1097-0215(19960117)65:2<221::AID-IJC16>3.0.CO;2-G. Int J Cancer. 1996. PMID: 8567121

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

204 results

Search Page

Filters